Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Jones, Lee W ^a   Douglas, Pamela S ^a   Eves, Neil D ^b   Marcom, P Kelly ^a   Kraus, William E ^a   Herndon II, James E ^a   Inman, Brant A ^a   Allen, Jason D ^a   Peppercorn, Jeffrey ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; OXYGEN;

AEROBIC EXERCISE; ARTICLE; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CARDIOPULMONARY EXERCISE TEST; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MUSCLE STRETCHING; OXYGEN CONSUMPTION; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SOCIAL INTERACTION; THERAPY EFFECT; TREADMILL EXERCISE; TREATMENT DURATION; BREAST TUMOR; CHEMISTRY; EXERCISE; KINESIOTHERAPY; METHODOLOGY; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; WALKING;

BIOLOGICAL MARKERS; BREAST NEOPLASMS; EXERCISE; EXERCISE THERAPY; FEMALE; HUMANS; OXYGEN; OXYGEN CONSUMPTION; POSTMENOPAUSE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TREATMENT OUTCOME; WALKING;

EID: 77957294105     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-531     Document Type: Article

References (43)

1. Balady GJ. Survival of the fittest--more evidence. N Engl J Med 2002, 346(11):852-854. 10.1056/NEJM200203143461111, 11893798.
2. Kraus WE, Douglas PS. Where does fitness fit in?. N Engl J Med 2005, 353(5):517-519. 10.1056/NEJMe058132, 16079377.
3. Jones LW, Eves ND, Haykowsky M, Freedland SJ, Mackey JR. Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction. Lancet Oncol 2009, 10(6):598-605. 10.1016/S1470-2045(09)70031-2, 19482248.
4. Gulati M, Pandey DK, Arnsdorf MF, Lauderdale DS, Thisted RA, Wicklund RH, Al-Hani AJ, Black HR. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation 2003, 108(13):1554-1559. 10.1161/01.CIR.0000091080.57509.E9, 12975254.
5. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002, 346(11):793-801. 10.1056/NEJMoa011858, 11893790.
6. Ekelund LG, Haskell WL, Johnson JL, Whaley FS, Criqui MH, Sheps DS. Physical fitness as a predictor of cardiovascular mortality in asymptomatic North American men. The Lipid Research Clinics Mortality Follow-up Study. N Engl J Med 1988, 319(21):1379-1384. 10.1056/NEJM198811243192104, 3185648.
7. Mora S, Redberg RF, Cui Y, Whiteman MK, Flaws JA, Sharrett AR, Blumenthal RS. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. Jama 2003, 290(12):1600-1607. 10.1001/jama.290.12.1600, 14506119.
8. Sandvik L, Erikssen J, Thaulow E, Erikssen G, Mundal R, Rodahl K. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men. N Engl J Med 1993, 328(8):533-537. 10.1056/NEJM199302253280803, 8426620.
9. Jones LW, Haykowsky MJ, Swartz JJ, Douglas PS, Mackey JR. Early breast cancer therapy and cardiovascular injury. J Am Coll Cardiol 2007, 50(15):1435-1441. 10.1016/j.jacc.2007.06.037, 17919562.
10. Ganz PA. Harnessing personalised medicine to prevent late effects. Lancet Oncol 11(1):7-9. 10.1016/S1470-2045(09)70344-4, 19931488.
11. Jones LW, Haykowsky M, Peddle CJ, Joy AA, Pituskin EN, Tkachuk LM, Courneya KS, Slamon DJ, Mackey JR. Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab. Cancer Epidemiol Biomarkers Prev 2007, 16(5):1026-1031. 10.1158/1055-9965.EPI-06-0870, 17507633.
12. Jones LW, Haykowsky M, Pituskin EN, Jendzjowsky NG, Tomczak CR, Haennel RG, Mackey JR. Cardiovascular reserve and risk profile of postmenopausal women after chemoendocrine therapy for hormone receptor--positive operable breast cancer. Oncologist 2007, 12(10):1156-1164. 10.1634/theoncologist.12-10-1156, 17962609.
13. Herrero F, Balmer J, San Juan AF, Foster C, Fleck SJ, Perez M, Canete S, Earnest CP, Lucia A. Is cardiorespiratory fitness related to quality of life in survivors of breast cancer?. J Strength Cond Res 2006, 20(3):535-540. 10.1519/R-18215.1, 16977706.
14. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. Jama 2005, 293(20):2479-2486. 10.1001/jama.293.20.2479, 15914748.
15. Irwin ML, Smith AW, McTiernan A, Ballard-Barbash R, Cronin K, Gilliland FD, Baumgartner RN, Baumgartner KB, Bernstein L. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 2008, 26(24):3958-3964. 10.1200/JCO.2007.15.9822, 2654316, 18711185.
16. Haykowsky MJ, Mackey JR, Thompson RB, Jones LW, Paterson DI. Adjuvant trastuzumab induces ventricular remodeling despite aerobic exercise training. Clin Cancer Res 2009, 15(15):4963-4967. 10.1158/1078-0432.CCR-09-0628, 19622583.
17. McNeely ML, Campbell KL, Rowe BH, Klassen TP, Mackey JR, Courneya KS. Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. Cmaj 2006, 175(1):34-41. 1482759, 16818906.
18. Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, Dipietro L, Mayne ST, Yu H. Randomized Controlled Trial of Aerobic Exercise on Insulin and Insulin-like Growth Factors in Breast Cancer Survivors: The Yale Exercise and Survivorship Study. Cancer Epidemiol Biomarkers Prev 2009, 18(1):306-313. 10.1158/1055-9965.EPI-08-0531, 2841479, 19124513.
19. Ligibel JA, Campbell N, Partridge A, Chen WY, Salinardi T, Chen H, Adloff K, Keshaviah A, Winer EP. Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors. J Clin Oncol 2008, 26(6):907-912. 10.1200/JCO.2007.12.7357, 18281663.
20. Schmitz KH, Courneya KS, Matthews C, Demark-Wahnefried W, Galvao DA, Pinto BM, Irwin ML, Wolin KY, Segal RJ, Lucia A, et al. American college of sports medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42(7):1409-1426.
21. Rognmo O, Hetland E, Helgerud J, Hoff J, Slordahl SA. High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2004, 11(3):216-222. 10.1097/01.hjr.0000131677.96762.0c, 15179103.
22. Hambrecht R, Walther C, Mobius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation 2004, 109(11):1371-1378. 10.1161/01.CIR.0000121360.31954.1F, 15007010.
23. Giannuzzi P, Temporelli PL, Corra U, Tavazzi L. Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 2003, 108(5):554-559. 10.1161/01.CIR.0000081780.38477.FA, 12860904.
24. Wisloff U, Stoylen A, Loennechen JP, Bruvold M, Rognmo O, Haram PM, Tjonna AE, Helgerud J, Slordahl SA, Lee SJ, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007, 115(24):3086-3094. 10.1161/CIRCULATIONAHA.106.675041, 17548726.
25. Gordon A, Tyni-Lenne R, Jansson E, Jensen-Urstad M, Kaijser L. Beneficial effects of exercise training in heart failure patients with low cardiac output response to exercise - a comparison of two training models. J Intern Med 1999, 246(2):175-182. 10.1046/j.1365-2796.1999.00555.x, 10447786.
26. Duscha BD, Slentz CA, Johnson JL, Houmard JA, Bensimhon DR, Knetzger KJ, Kraus WE. Effects of exercise training amount and intensity on peak oxygen consumption in middle-age men and women at risk for cardiovascular disease. Chest 2005, 128(4):2788-2793. 10.1378/chest.128.4.2788, 16236956.
27. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, Loennechen JP, Al-Share QY, Skogvoll E, Slordahl SA, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008, 118(4):346-354. 10.1161/CIRCULATIONAHA.108.772822, 2777731, 18606913.
28. Jones LW, Courneya KS. Exercise counseling and programming preferences of cancer survivors. Cancer Pract 2002, 10(4):208-215. 10.1046/j.1523-5394.2002.104003.x, 12100105.
29. Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC, Macera CA. Castaneda-Sceppa C: Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116(9):1094-1105. 10.1161/CIRCULATIONAHA.107.185650, 17671236.
30. Kreider ME, Grippi MA. Impact of the new ATS/ERS pulmonary function test interpretation guidelines. Respir Med 2007, 101(11):2336-2342. 10.1016/j.rmed.2007.06.019, 17686622.
31. Parisi AF, Moynihan PF, Feldman CL, Folland ED. Approaches to determination of left ventricular volume and ejection fraction by real-time two-dimensional echocardiography. Clin Cardiol 1979, 2(4):257-263. 10.1002/clc.4960020404, 262574.
32. Schiller NB, Acquatella H, Ports TA, Drew D, Goerke J, Ringertz H, Silverman NH, Brundage B, Botvinick EH, Boswell R, et al. Left ventricular volume from paired biplane two-dimensional echocardiography. Circulation 1979, 60(3):547-555.
33. Allen JD, Cobb FR, Gow AJ. Regional and whole-body markers of nitric oxide production following hyperemic stimuli. Free Radic Biol Med 2005, 38(9):1164-1169. 10.1016/j.freeradbiomed.2004.12.018, 15808413.
34. Duscha BD, Kraus WE, Keteyian SJ, Sullivan MJ, Green HJ, Schachat FH, Pippen AM, Brawner CA, Blank JM, Annex BH. Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations. J Am Coll Cardiol 1999, 33(7):1956-1963. 10.1016/S0735-1097(99)00101-1, 10362199.
35. Kraus WE, Torgan CE, Duscha BD, Norris J, Brown SA, Cobb FR, Bales CW, Annex BH, Samsa GP, Houmard JA, et al. Studies of a targeted risk reduction intervention through defined exercise (STRRIDE). Med Sci Sports Exerc 2001, 33(10):1774-1784. 10.1097/00005768-200110000-00025, 11581566.
36. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S, Cobleigh M, Shiomoto G. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. J Clin Oncol 1997, 15(3):974-986.
37. Yellen SB, Cella DF, Webster K, Blendowski C, Kaplan E. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage 1997, 13(2):63-74. 10.1016/S0885-3924(96)00274-6, 9095563.
38. Radloff LS. The CES-D scale: A self report depression scale for research in the general population. Applied Psychological Measurement 1977, (1):385-401.
39. Nikolinakos PG, Altorki N, Yankelevitz D, Tran HT, Yan S, Rajagopalan D, Bordogna W, Ottesen LH, Heymach JV. Plasma cytokine and angiogenic factor profiling identifies markers associated with tumor shrinkage in early-stage non-small cell lung cancer patients treated with pazopanib. Cancer Res 70(6):2171-2179. 10.1158/0008-5472.CAN-09-2533, 20215520.
40. Hanrahan EO, Lin HY, Kim ES, Yan S, Du DZ, McKee KS, Tran HT, Lee JJ, Ryan AJ, Langmuir P, et al. Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancer. J Clin Oncol 28(2):193-201. 10.1200/JCO.2009.22.4279, 19949019.
41. Jones LW, Peppercorn J. Exercise research: early promise warrants further investment. Lancet Oncol 11(5):408-410. 10.1016/S1470-2045(10)70094-2, 20434709.
42. Jones LW, Eves ND, Peterson BL, Garst J, Crawford J, West MJ, Mabe S, Harpole D, Kraus WE, Douglas PS. Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical nonsmall cell lung cancer patients: a pilot study. Cancer 2008, 113(12):3430-3439. 10.1002/cncr.23967, 18988290.
43. Jones LW, Peddle CJ, Eves ND, Haykowsky MJ, Courneya KS, Mackey JR, Joy AA, Kumar V, Winton TW, Reiman T. Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer 2007, 110(3):590-598. 10.1002/cncr.22830, 17582629.